Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Contraf-Nicotex-Tobacco
Heilbronn, Baden-Württemberg, Germanycntgroup.de ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Contraf-Nicotex-Tobacco is the world’s largest supplier of highly purified, tobacco-derived nicotine for the pharmaceutical industry, with its nicotine registered and referenced for pharmaceutical use globally. The company does not develop finished dosage forms or clinical drugs itself but supplies pharmaceutical-grade nicotine as an ingredient for smoking cessation and e-cigarette products[4].
- Therapeutic areas
- PsychiatryOther
- Modalities
- Small moleculeNicotine
- Industry
- Chemicals & Materials
02
Partnerships
Siegfried AG (contract manufacturing partner in Switzerland for nicotine[4])
Beyond the preview
Go deeper on Contraf-Nicotex-Tobacco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Contraf-Nicotex-Tobacco.